{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:08:46Z","timestamp":1761491326122,"version":"3.41.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.htct.2021.09.017","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T08:06:48Z","timestamp":1638864408000},"page":"13-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8473-202X","authenticated-orcid":false,"given":"Roberto","family":"Crocchiolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Alfarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Volpato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariateresa","family":"Pugliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Cuppari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bellio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Vismara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Pollichieni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7733-6862","authenticated-orcid":false,"given":"Lia","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Diral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvano","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Aggiornamento Delle Misure Di Prevenzione Della Trasmissione Dell\u00b4Infezione Da Nuovo Coronavirus (SARS-CoV-2) in Italia attraverso Il Trapianto Di organi, Tessuti e Cellule\u201d","author":"Prot. 503\/CNT 2020 Del 3 Marzo","key":"10.1016\/j.htct.2021.09.017_bib0001"},{"key":"10.1016\/j.htct.2021.09.017_bib0002","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood.2020008230","article-title":"No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation","volume":"136","author":"Cappy","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.htct.2021.09.017_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103105","article-title":"Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies","volume":"60","author":"Gambacorti-Passerini","year":"2021","journal-title":"Transfus Apher Sci"},{"issue":"11","key":"10.1016\/j.htct.2021.09.017_bib0004","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/s41409-020-0919-0","article-title":"The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy","volume":"55","author":"Ljungman","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.htct.2021.09.017_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(21)00025-9","article-title":"Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors","volume":"8","author":"Leclerc","year":"2021","journal-title":"Lancet Haematol"},{"issue":"12","key":"10.1016\/j.htct.2021.09.017_bib0006","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/s41409-020-0969-3","article-title":"Hematopoietic stem cell transplantation from an infected SARS-CoV-2 donor sibling","volume":"55","author":"Anurathapan","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.htct.2021.09.017_bib0007","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbmt.2020.04.001","article-title":"Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis","volume":"26","author":"Hamadani","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.htct.2021.09.017_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236311","article-title":"Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients","volume":"15","author":"Alteri","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.htct.2021.09.017_bib0009","first-page":"181","article-title":"SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan","volume":"19","author":"Valenti","year":"2021","journal-title":"Blood Transfus"},{"key":"10.1016\/j.htct.2021.09.017_bib0010","article-title":"Negative nasopharyngheal and oropharyngeal swabs do not rule out COVID-19","volume":"58","author":"Valenti","year":"2020","journal-title":"J Clin Microbiol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921013341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137921013341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:43:44Z","timestamp":1749757424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137921013341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2531137921013341"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2021.09.017","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-COV-2 screening in allogeneic hematopoietic stem cell donors: Implications for the evaluation process and eligibility","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2021.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}